TRAF2 is associated with breast cancer progression and metastasis73, is a member of the tumor necrosis factor receptor-associated factor family of intracellular signal transduction proteins, and is a critical mediator of both the activation of NF-κB and MAPK pathways74. The gene discussed is NFKB1; the disease is breast carcinoma.